Imprinting centers (IC) can be defined as cis-elements that are recognized in the germ line and are epigenetically modified to bring about the full imprinting program in a somatic cell. Two paternally expressed human genes, HYMAI and PLAGL1 (LOT1/ZAC), are located within human chromosome 6q24. Within this region lies a 1-kb CpG island that is differentially methylated in somatic cells, unmethylated in sperm, and methylated in mature oocytes in mice, characteristic features of an IC. Loss of methylation of the homologous region in humans is observed in patients with transient neonatal diabetes mellitus and hypermethylation is associated with a variety of cancers, suggesting that this region regulates the expression of one or more key genes in this region involved in these diseases. We now report that a transgene carrying the human HYMAI/PLAGL1 DMR was methylated in the correct parent-origin-specific manner in mice and this was sufficient to confer imprinted expression from the transgene. Therefore, we propose that this DMR functions as the IC for the HYMAI/PLAGL1 domain.
Imprinting is a non-Mendelian form of inheritance in which only one of the two inherited alleles is expressed. This is dependent on differential epigenetic marking of the two parental alleles in the germ line [1] [2] [3] [4] . The differential expression of imprinted genes accounts for the requirement for both maternal and paternal genomes in normal development [5, 6] . Many imprinted genes play significant roles in regulating embryo growth, placental function, and neurobehavioral processes (summarized in http://www.mgu.har.mrc.ac. uk/research/imprinting/function.html). Studies of a number of chromosomal domains have demonstrated that imprinted genes are predominantly located in clusters, where they exhibit a complex sharing of control elements [7] [8] [9] . This regulation appears to be mediated by imprinting centers (IC). IC are responsible for the establishment of differential imprinted genomic marks in the germ line, the maintenance of these marks through development, and the ultimate execution of differential expression programs for the two parental alleles [10] . The most likely candidate for the gametic mark that distinguishes the parental alleles is DNA methylation [1] . DNA methylation is a both heritable and reversible epigenetic modification that is stably propagated after DNA replication and influences gene expression [11] . Allele-specific DNA methylation has been observed within all well-characterized imprinted domains. In some instances, the methylation is present at the promoter of the inactive gene, suggesting a direct role for DNA methylation in silencing of the gene.
We previously identified the human imprinted region at chromosome 6q24, syntenic to mouse chromosome 10A, in a screen for imprinted genes [12, 13] . Two paternally expressed human genes are located in this domain, HYMAI and PLAGL1 (LOT1/ZAC) [12, 14, 15] . HYMAI generates an untranslated mRNA of unknown function, while PLAGL1 encodes a zinc finger protein that localizes to the nuclear compartment and functions as a transcription factor [16] . We showed that a CpG island overlapping exon 1 of PLAGL1/HYMAI is differentially methylated in somatic cells [17] . The region is unmethylated in sperm but methylated in growing oocytes, a difference that persists between parental alleles throughout pre-and postimplantation development. A region within this differentially methylated CpG island exhibits a high degree of homology between mouse and human [17, 18] . We and others have recently shown that acquisition of oocyte methylation at the mouse Hymai/Plagl1 CpG island is completed in early growing oocytes at the same time as the primary imprinting of Plagl1 expression [19, 20] . These features led us to suggest that this CpG island marks the position of the IC for this domain.
Evidence supporting a role for this CpG island in regulating gene expression comes from studies on human cancers. Hypermethylation of this region leading to transcriptional silencing of PLAGL1 has been reported in a variety of human cancers, including ovarian cancer [21, 22] . Furthermore, patients with transient neonatal diabetes mellitus consistently show loss of methylation at this CpG island [23] .
Previously, IC have been defined by genetic analysis using deletions to map the elements that may be necessary for this process or by using transgenes in mice to determine the minimal sequence information sufficient to carry out the full imprinting program [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] [37] [38] [39] [40] [41] . There is evidence that an IC lies within a 175-kb region spanning the human PLAGL1/HYMAI locus since a PAC clone carrying this sequence is apparently able to direct imprinted expression of PLAGL1 in mice [42] . In this study, we examined the imprinting capabilities of a much smaller region, the human HYMAI/PLAGL1 differentially methylated CpG island, in transgenic mice. We found that the human HYMAI/ PLAGL1 CpG island can acquire parental-origin-specific methylation in the maternal germ line and that this modulates expression of a linked reporter. This supports our hypothesis that this CpG island is the IC for the HYMAI/PLAGL1 imprinted domain.
Results

Production of transgenic mice
To test whether the human HYMAI/PLAGL1 DMR might be sufficient to promote a parent-origin-specific methylation pattern and imprinted expression in the mouse, we constructed a human HYMAI/PLAGL1 DMR reporter transgene by cloning the DMR into the pIRES-eGFP vector (Fig. 1A) . We generated 28 founder animals by pronuclear injection, which were initially identified in a PCR screen (28/200) . To determine the copy number of the integrated transgenes, we performed Southern blotting using the same amount of DNA in human placenta and compared it to the density of the band using the densitometer (Table 1) . We then crossed transgenic founders with the wild-type C57BL/ 6J mice to establish independent lines. We obtained germline transmission of the transgene in 13 independent lines, 6 lines from male founders and 7 lines from female founders. We also made transgenic mice with only the pIRES-eGFP vector as a control.
Allele-specific methylation of the human HYMAI/PLAGL1 DMR in transgenic mice
The endogenous human HYMAI/PLAGL1 DMR has a maternal-origin-specific methylation pattern [17, 19] . We examined the methylation pattern of the transgene inherited from the male and female founders in F1 individuals. Tail DNA from one transgenic F1 animal was analyzed for each line. DNA was digested with XhoI and BamHI and the methylation-sensitive restriction enzymes NotI and/or SmaI. We performed Southern blot using the human HYMAI/PLAGL1 DMR probe (shown in Fig. 1A ). We found that the six lines for which the founder was male showed the unmethylated pattern as would be predicted for paternal inheritance of this DMR. Six of the lines for which the founder was female showed either full or partial methylation, again consistent with this region acquiring the germ-lineappropriate mark, and 1 line demonstrated the unmethylated pattern (Fig. 1B) . These results were confirmed by bisulfite analysis. After bisulfite treatment of the DNA samples, the human HYMAI/PLAGL1 DMR was amplified by PCR, fragments were subcloned and sequenced, and methylation status was determined at the 17 CpG sites of the human HY-MAI/PLAGL1 DMR. Results are shown in Fig. 1B and Table 1 and were consistent with the data obtained by Southern blotting.
For an IC to function, not only must the epigenetic mark be made in the appropriate germ line but also it must be erased so that the appropriate, sex-specific mark can be reestablished for the next generation and to switch back and forth from the male to the female imprint. We therefore chose to examine the ability of our transgene to switch imprint in line 68, whose founder was originally male, and in line 12, whose founder was female. For line 68, we found that the F1 female, who had inherited an unmethylated DMR from her male parent, passed on a methylated DMR to all six of her offspring (Fig.  1C) . Therefore in this line, the imprint switched from unmethylated (male) to methylated (female). For line 12, the male F1 animal that had inherited a methylated DMR from his female parent passed on an unmethylated DMR to six of his offspring, again showing appropriate switching. Lines 8, 21, 25, 29, 55, 62, 69, and 81 showed similar switching (data not shown).
Finally, we examined whether the methylation imprint persisted. We examined methylation after both paternal and maternal transmission in the F2 generation by Southern blotting and bisulfite-modified genomic sequencing (Fig.  1D) . The appropriate switch was again observed.
DNA methylation of the human HYMAI/PLAGL1 DMR modulates expression of the linked reporter DNA methylation influences gene expression. In some instances, the methylation is present on the inactive gene, suggesting a role for DNA methylation in silencing of the The copy number and methylation pattern of the human HYMAI/PLAGL1 DMR transgene for paternal and maternal transmission from founder animals are shown. % methylation of the human HYMAI/PLAGL1 DMR was obtained by bisulfite-PCR sequencing.
gene. We therefore examined whether the methylation status of the transgene had an affect on eGFP reporter gene expression. We performed Northern blotting of the mRNA from F3 neonate liver after male or female transmission for line 12 and line 68 ( Fig. 2A) . For line 12, we found that the eGFP mRNA was expressed more highly after paternal transmission (unmethylated transgene) than after maternal transmission (methylated transgenes). Some expression from the methylated transgene was detectable, which suggests that the DNA methylation was not able to suppress all transcription completely. This may be because the hybrid sequence is not able to respond exactly as an imprinted gene or perhaps be due to copy number. Nonetheless, there is still a distinct difference in the level of expression after maternal and paternal transmission suggesting that this DNA region can act to regulate allele-specific gene expression. A similar pattern was obtained for line 68 ( Fig. 2A) . Next, we analyzed whether appropriate allele-specific expression from the transgene was also present in the placenta and whether it persisted in adult tissues. Expression of eGFP was detected strongly in brain, kidney, and placenta after male transmission (Fig. 2B) , with weaker expression in the liver, lung, and spleen. After female transmission, a similar but much lower level of expression was observed in these tissues, demonstrating that the imprint-linked expression was preserved into adulthood and in extraembryonic tissues (Fig. 2B) .
Silencing of the HYMAI/PLAGL1 DMR transgene in the nongrowing oocytes
The establishment of methylation imprints proceeds in a gene-specific manner while oocytes are arrested at prophase I and transitioned from primordial to antral follicle [43] [44] [45] . We previously reported that the acquisition of the methylation imprint of the mouse Hymai/Plagl1 DMR begins around 5 days postpartum (dpp) in the early nongrowing oocyte and the primary imprinting of Plagl1 is completed during the 5-to 10-dpp oocyte growth phase [20] . We examined whether imprinting of our transgene followed this time scale. eGFP expression was determined in 5-, 10-, and 15-dpp ovaries from juvenile mice using immunofluorescence microscopy (Fig. 3) . Almost all oocytes from the primordial follicle in 5-dpp ovaries showed strong expression of eGFP (percentage of highly expressed oocytes, 82.8%, 92/111 (n = 5)). However, the 10-dpp early growing oocytes showed a mixture of high expression (45.7%, 32/70 (n = 5)) and low expression (38.5%, 27/70 (n = 5)). Almost all of the germ cells from 15-dpp oocytes derived from early antral follicles showed no expression of eGFP (12.2%, 4/33 (n = 5)). These data suggest that the human DMR acquires the maternal silencing imprint during the 5-to 10-dpp oocyte growth stage in a fashion similar to that of the mouse DMR.
In conclusion, we have shown that a 936-bp region of the human PLAGL1 DMR can be recognized by the imprinting machinery of the mouse germ line and correctly methylated in the female germ line at the time point at which the endogenous mouse DMR is known to acquire an imprint. Furthermore, the DNA methylation is able, at least in part, to silence expression of a linked reporter gene on our construct, suggesting that this sequence forms part of the IC from the human HYMAI/PLAGL1 imprinted domain.
Discussion
Despite the apparent conservation of imprinting among mammals, there are few examples of human transgenes imprinting appropriately in mice [38, 39, [46] [47] [48] . Furthermore, there are few data available to show that small regions can reliably direct imprinting on transgenes, thus making the precise dissection of these regions quite challenging. Here we have shown that a small (936 bp) region from the human HYMAI/ PLAGL1 DMR can acquire the appropriate maternal-specific methylation in the mouse germ line and that this robust methylation imprint can switch back and forth between the germ lines for three generations (Fig. 4) . This region was previously shown to contain maternal-specific methylation in humans [12, 14] as well as in mice [17] . This demonstrates first that, at least for this DMR, there is no species barrier between human and mouse in the imprinting mechanism. In contrast, imprint acquisition of human H19 DMR does not appear to be conserved in transgenic mice [38] . Although we cannot exclude the possibility that the human DMR acts only in the context of the IRES-eGFP transgene, this work provides further evidence that this region is the major IC for the HYMAI/PLAGL1 domain.
The basic principles that govern the establishment and maintenance of domain-wide imprinted gene expression patterns have been elucidated in a general manner and seem to be mediated at the molecular level by DMRs. The order of events and all the players are still to be elucidated. Our findings will make this process easier as we can focus all our efforts on a much smaller region, identifying proteins that bind to this sequence in extracts from different material, such as mouse oocytes, at different stages of development and establishment of the imprint. Having defined an IC within a 936-bp sequence, we can now proceed to analyze this region base by base to identify the sequence motif recognized in the female germ line that establishes DNA methylation or, conversely, a sequence motif that blocks DNA methylation in the male germ line.
Materials and methods
Production and analysis of human HYMAI/PLAGL1 DMR transgenic mice
The eGFP-tagged HYMAI/PLAGL1 DMR mammalian expression vector was constructed by cloning a 936-bp fragment spanning the human HYMAI/ PLAGL1 DMR into the XhoI and BamHI sites upstream of the IRES of the pIRES-eGFP vector (Clontech, Palo Alto, CA, USA). DNA was purified using a midiprep kit (Qiagen, Tokyo, Japan) and linearized by XhoI digestion prior to microinjection into F1 (C57BL/6J × CBA) embryos. Embryos were then transferred to C57BL/6J pseudopregnant females, all according to standard procedures [49] . Genomic DNA was isolated from the tail biopsy of newborn mice as described previously [14] . The transgenic event was initially examined using two kinds of PCR to detect the human HYMAI/PLAGL1 DMR and the eGFP fragment, respectively. Primers used for the HYMAI/PLAGL1 DMR were 5″-AGTATGTCTGATACAGTCTG-3″ and 5″-TTTGCGCGCCGCC-TACGTG-3″ and for eGFP were 5″-CGCACCATCTTCTTCAAGGACG-3″ and 5″-TGCTCAGGTAGTGGTTGTCG-3′. The amplification consisted of a total of 30 cycles at 95°C for 30 s, 65°C for 30 s, and 72°C for 30 s in a PerkinElmer GeneAmp PCR System 2400. After PCR screening, we performed Southern blotting to determine the copy number of the transgenic integrations by comparison with a known quantity of human placental genomic DNA. Genomic DNAs (5 μg) were digested with XhoI and BamHI. Filters were probed with a [ 
Methylation analysis
Genomic DNAs of the transgenic mice were digested with XhoI and BamHI and a methylation-sensitive endonuclease, NotI and/or SmaI, followed by electrophoresis on 1% agarose gels. Southern blots were performed using a 936-bp fragment from the human HYMAI/PLAGL1 DMR.
Bisulfite treatment was carried using the EZ DNA methylation kit (Zymo Research, CA, USA) according to the manufacturer's instructions. Different samples of bisulfite-treated DNA were amplified by single PCR of the human DMR. The primer sequences and PCR conditions for the HYMAI/PLAGL1 DMR were as described previously [19] . The amplified fragments were cloned into the TOPO TA vector (Invitrogen, Tokyo, Japan) and individual clones were sequenced using a T7 primer and/or M13 reverse primer.
Northern blot analysis
Total RNA was isolated from neonate liver and adult organs using Isogen (Nippon Gene, Tokyo, Japan). Northern blot analysis was carried out as previously described [17] . eGFP cDNA (321 bp; pIRES2-eGFP vector 1542-1863) was used as a probe. Gene expression was quantified on the BAS 2000 system (Fuji Film) and normalized for total RNA by rehybridizing with Gapdh (Clontech). The relative intensity of eGFP is presented as an eGFP/Gapdh ratio.
GFP analysis
Sections were observed by immunofluorescence microscopy (LSM510-META, Zeiss, Germany, and SZY9, Olympus, Japan). The ovaries of F3 transgenic mice at 5, 10, and 15 dpp were used in the analysis of eGFP expression in their oocytes.
